McIntyre B A, Philp R B, Inwood M J
Clin Pharmacol Ther. 1978 Nov;24(5):616-21. doi: 10.1002/cpt1978245616.
New propionic acid derivatives are claimed to induce a lower incidence of gastrointestinal bleeding and hemostatic disturbance than older anti-inflammatory analgesics such as aspirin. One of these (ibuprofen, Motrin) was given (600 mg orally) to normal subjects and hemophiliac subjects on a random, double-blind basis (lactose placebo). Platelet adhesiveness, aggregation, platelet and red cell counts, percent packed cells, percent hemoglobin, serum ibuprofen levels, and modified Ivy bleeding time were measured before and 2 and 24 hr after drug. Predrug and 24-hr postdrug values were normal, but at 2 hr after drug, adenosine diphosphate, epinephrine, and collagen aggregations were inhibited and bleeding times were slightly but significantly prolonged in the ibuprofen-treated normal subjects. The other parameters tested remained unchanged. Similar results were obtained in the ibuprofen-treated hemophiliac patients, although bleeding time was not prolonged. The results suggest that ibuprofen may be given to hemophiliac subjects with greater safety than some of the older anti-inflammatory drugs.
据称,新型丙酸衍生物引发胃肠道出血和止血障碍的发生率低于阿司匹林等较老的抗炎镇痛药。其中一种(布洛芬,Motrin)以随机、双盲方式(乳糖安慰剂)给予正常受试者和血友病患者(口服600毫克)。在给药前以及给药后2小时和24小时测量血小板黏附性、聚集性、血小板和红细胞计数、血细胞比容百分比、血红蛋白百分比、血清布洛芬水平以及改良的Ivy出血时间。给药前和给药后24小时的值正常,但在给药后2小时,布洛芬治疗的正常受试者中,二磷酸腺苷、肾上腺素和胶原诱导的聚集受到抑制,出血时间略有延长但显著延长。所测试的其他参数保持不变。在布洛芬治疗的血友病患者中也获得了类似结果,尽管出血时间没有延长。结果表明,与某些较老的抗炎药相比,布洛芬给予血友病患者可能具有更高的安全性。